Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake:In Silicoand Clinical Evaluations-Reference-Cited by-同舟云学术

Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake:In Silicoand Clinical Evaluations

Published:2017-12-08 Issue:2 Volume:104 Page:374-383
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Samant Tanay S.¹,Dhuria Shyeilla²,Lu Yasong¹,Laisney Marc³,Yang Shu¹,Grandeury Arnaud³,Mueller-Zsigmondy Martin³,Umehara Kenichi³,Huth Felix³,Miller Michelle¹,Germa Caroline¹,Elmeliegy Mohamed¹

Affiliation:

1. Novartis Pharmaceuticals; East Hanover New Jersey USA

2. Achaogen; South San Francisco California USA

3. Novartis Pharma; Basel Switzerland

Funder

Novartis

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.940/fullpdf

Reference45 articles.

1. Kim , S. et al LEE011: an orally bioavailable, selective small molecule inhibitor of CDK4/6-reactivating Rb in cancer 2013

2. Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma;Rader;Clin. Cancer Res.,2013

3. Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo;Zhang;Mol. Cancer Ther.,2014

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions;European Journal of Drug Metabolism and Pharmacokinetics;2024-08-06

2. Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments;Critical Reviews in Oncology/Hematology;2024-08

3. Estimation of CDK inhibitors by RP-HPLC: application for pharmacokinetic interactions studies with PPIs;Bioanalysis;2024-07-17

4. Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis;Frontiers in Pharmacology;2024-05-06

5. Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling;The AAPS Journal;2024-04-24